Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Ordinary Shares / American Depositary Shares
-
Shares outstanding
-
384M
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
3.31M
-
Shares change
-
+16.6K
-
Total reported value, excl. options
-
$15.9M
-
Value change
-
-$114K
-
Number of buys
-
8
-
Number of sells
-
-8
-
Price
-
$4.80
Significant Holders of Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) as of Q1 2022
19 filings reported holding CMMB - Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares as of Q1 2022.
Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.31M shares
of 384M outstanding shares and own 0.86% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2.58M shares), Cormorant Asset Management, LP (288K shares), Ikarian Capital, LLC (268K shares), BOOTHBAY FUND MANAGEMENT, LLC (41.3K shares), STATE STREET CORP (35.4K shares), MEITAV DASH INVESTMENTS LTD (35K shares), RENAISSANCE TECHNOLOGIES LLC (28K shares), GEODE CAPITAL MANAGEMENT, LLC (11.7K shares), ENVESTNET ASSET MANAGEMENT INC (10.8K shares), and ADVISOR GROUP HOLDINGS, INC. (7.14K shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.